Samuel C. Nalle, Ph.D. - Publications

Affiliations: 
2011 Pathology University of Chicago, Chicago, IL 
Area:
Immunology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nalle SC, Zuo L, Ong MLDM, Singh G, Worthylake AM, Choi W, Manresa MC, Southworth AP, Edelblum KL, Baker GJ, Joseph NE, Savage PA, Turner JR. Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability. The Journal of Clinical Investigation. PMID 30667372 DOI: 10.1172/Jci98554  0.614
2015 Nalle SC, Turner JR. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunology. 8: 720-30. PMID 25943273 DOI: 10.1038/Mi.2015.40  0.612
2014 Nalle SC, Kwak HA, Edelblum KL, Joseph NE, Singh G, Khramtsova GF, Mortenson ED, Savage PA, Turner JR. Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease. Science Translational Medicine. 6: 243ra87. PMID 24990882 DOI: 10.1126/Scitranslmed.3008941  0.596
2013 Su L, Nalle SC, Shen L, Turner ES, Singh G, Breskin LA, Khramtsova EA, Khramtsova G, Tsai PY, Fu YX, Abraham C, Turner JR. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology. 145: 407-15. PMID 23619146 DOI: 10.1053/J.Gastro.2013.04.011  0.632
2012 Nalle SC, Turner JR. Endothelial and epithelial barriers in graft-versus-host disease. Advances in Experimental Medicine and Biology. 763: 105-31. PMID 23397621 DOI: 10.1007/978-1-4614-4711-5_5  0.539
2011 Tang X, Nalle SC, Shen L, Matthews JB, Bouyer P. Knock-Down of Irbit (Inositol-1,4,5-Trisphosphate Receptor Binding Protein Released With IP3) Increases Epithelial Paracellular Permeability Gastroenterology. 140: S-503. DOI: 10.1016/S0016-5085(11)62084-2  0.42
2011 Nalle SC, Joseph NE, Savage PA, Turner JR. Intestinal Damage and Myosin Light Chain Kinase (MLCK)-Dependent Epithelial Barrier Dysfunction Are Vital to Minor Mismatch Graft-Versus-Host Disease Gastroenterology. 140: S-167. DOI: 10.1016/S0016-5085(11)60677-X  0.558
2010 Nalle SC, Savage PA, Turner JR. Total Body Irradiation Creates a Proinflammatory Milieu That Is Required for Minor, but Not Major, Mismatch Graft-Versus-Host-Disease. Blood. 116: 3736-3736. DOI: 10.1182/Blood.V116.21.3736.3736  0.46
2009 Nalle SC, Turner JR. Menetrier's disease therapy: rebooting mucosal signaling. Science Translational Medicine. 1: 8ps10. PMID 20368184 DOI: 10.1126/Scitranslmed.3000438  0.437
2009 Nalle SC, Turner JR. Epithelium, tear down this wall! Cell Host & Microbe. 5: 1-2. PMID 19154980 DOI: 10.1016/J.Chom.2008.12.008  0.46
2009 Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology. 136: 551-63. PMID 19027740 DOI: 10.1053/J.Gastro.2008.10.081  0.647
2009 Su L, Nalle SC, Sullivan EA, Fu Y, Turner JR. 499 Genetic Ablation of Myosin Light Chain Kinase (MLCK) Limits Epithelial Barrier Dysfunction and Attenuates Experimental Inflammatory Bowel Disease (IBD) Gastroenterology. 136: A-81. DOI: 10.1016/S0016-5085(09)60365-6  0.539
2008 Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 1110-20. PMID 18711353 DOI: 10.1038/Labinvest.2008.78  0.492
Show low-probability matches.